Rx PHARMASIST.CA
The Pharmasist newsletter

Stay current in
Canadian pharmacy.

Pharmacy news, practice updates and fresh perspectives—delivered to your inbox.

Keep your practice informed

  • Canadian pharmacy news

    Follow the developments shaping the profession.

  • Prescriber updates

    Stay informed about newly licensed Ontario physicians.

  • What's new on Pharmasist

    Explore new resources, tools and learning opportunities.

Free newsletter

A useful addition to your inbox.

We'll send a confirmation link first. Privacy policy

Diagnostic fluorescent dye (tricarbocyanine)

Indocyanine Green

Dosage form
Tablet
Available strengths
25 mg/vial
Drug class
Diagnostic fluorescent dye (tricarbocyanine)
Common brand
Generic products

Clinical overview. Indocyanine green is an injectable fluorescent diagnostic dye used to measure cardiac output, assess liver function and blood flow, and image the blood vessels of the eye. It is administered by a healthcare professional and carries a rare but serious risk of anaphylaxis, particularly in patients with iodide allergy. It has minimal common side effects since it is not a treatment but a diagnostic tool used briefly during testing.

Indication

Common therapeutic uses

  • Indocyanine green for injection is used to measure cardiac output through indicator-dilution studies.
  • It is used to assess liver (hepatic) function and liver blood flow.
  • It is used in ophthalmic angiography to image the blood vessels of the eye.

Pregnancy

Risk assessment and monitoring considerations

  • No animal reproduction studies have been conducted with indocyanine green, and it is not known whether it can harm an unborn baby or affect fertility.
  • Indocyanine green should be given to a pregnant woman only if clearly indicated.

Breastfeeding

Infant exposure considerations

  • It is not known whether indocyanine green passes into breast milk, so caution is advised when it is given to a woman who is breastfeeding.

Geriatrics

Dosing and tolerability considerations

  • No overall differences in safety or effectiveness have been observed between older and younger patients receiving indocyanine green.

Pediatrics

Use in children and adolescents

  • Safety and effectiveness of indocyanine green have been established in children, including infants, with dosing based on body weight and adjusted lower than the adult dose.

Dosage & Administration

Practical dosing and administration

  • For cardiac output and indicator-dilution studies, the dose is weight- and age-based, given as a rapid single bolus injection through a cardiac catheter, with the total dye dose kept below 2 mg/kg.
  • For hepatic function studies, the dose is calculated at 0.5 mg per kilogram of body weight and injected rapidly into an arm vein in a fasting patient.
  • For ophthalmic angiography, doses of up to 40 mg are injected into the antecubital vein, immediately followed by a saline flush, with the exact amount depending on the imaging equipment used.
  • The reconstituted solution must be prepared under sterile conditions using Sterile Water for Injection and used within 6 hours of preparation; it should not be used if it appears hazy, discoloured, or contains particles.
  • Isotonic saline, not sterile water, should be used to flush residual dye from the injection catheter into the circulation, to avoid causing hemolysis.
  • No specific dose adjustment for renal or hepatic impairment is described, though hepatic function itself is often the reason for testing.

Overdose

Recognizing and responding to overdose

If overdose is suspected, seek emergency medical attention immediately or contact your regional Poison Control Centre without delay.

  • The product monograph does not describe specific signs, symptoms, or laboratory findings for indocyanine green overdose in humans.
  • Animal studies show the lethal dose is many times higher than the maximum human doses used for diagnostic testing, suggesting a wide margin of safety.
  • As with any suspected overdose, supportive care and monitoring are appropriate, with poison control consulted for guidance.

Common side effects

Frequently reported tolerability concerns

  • The product monograph does not report common, non-serious side effects from indocyanine green beyond the allergic-type reactions described under Serious side effects; most reported effects with this diagnostic dye are hypersensitivity-related rather than routine, low-grade effects.

Serious side effects

Findings that may require urgent assessment

Serious side effects require immediate discussion with the prescriber or emergency care.

  • Severe allergic reactions, including anaphylaxis and anaphylactic shock, have occurred and have been fatal in some cases, particularly during cardiac catheterization procedures.
  • Hives (urticaria) related to an allergic reaction may occur, with or without a prior history of allergy to iodine-containing substances.
  • Seek immediate medical attention for any signs of a severe allergic reaction, such as difficulty breathing, swelling of the face or throat, or a sudden drop in blood pressure, during or shortly after the injection.

Use with caution

Situations requiring closer assessment

  • Use with caution in patients with a history of allergy to iodides, since indocyanine green contains sodium iodide and carries a risk of anaphylaxis in this group.
  • Use with caution and have treatment for anaphylaxis, such as epinephrine, antihistamines, and corticosteroids, readily available whenever indocyanine green is administered.
  • Use with caution regarding solution stability, since the reconstituted dye is unstable in aqueous solution and must be used within 6 hours of preparation.

Contraindications

Situations where therapy may be inappropriate

  • Contraindicated in patients with known hypersensitivity to indocyanine green or to any ingredient in the formulation, including its iodide content.

Drug interactions

Clinically relevant combinations

  • Preparations containing sodium bisulfite, including some heparin products, can reduce the measured absorption peak of indocyanine green in blood and should not be used as the anticoagulant when collecting blood samples for analysis.
  • Radioactive iodine uptake studies should not be performed for at least a week after indocyanine green has been given, since the iodide content can interfere with the results.
  • Because indocyanine green binds strongly to plasma proteins, conditions or drugs that significantly alter blood protein levels could theoretically affect its measured clearance, although this has not been formally studied.

Food interactions

Meal-related administration

  • Indocyanine green is given only by intravenous injection in a clinical or hospital setting, so food timing does not apply to this medicine.

Time of administration

Practical scheduling

  • Indocyanine green is administered as a single injection by a healthcare professional at the time of the diagnostic test; for hepatic function testing, the patient is studied in a fasting state, but this relates to the accuracy of the test rather than a food interaction with the drug itself.

Storage

Product handling

  • Store indocyanine green vials at 15°C to 25°C.
  • Once reconstituted, the solution must be used within 6 hours and should not be stored for later use.
  • Although the reconstituted aqueous solution is unstable, indocyanine green is stable once bound to protein in whole blood or plasma, so blood samples taken during testing can be analyzed later without a rush.

Patient take-away

Key counselling points for a quick closing summary

  • Indocyanine green is a diagnostic dye given by injection to help your healthcare team assess your heart, liver, or eye blood vessels; it is not a treatment for a medical condition.
  • Tell your healthcare professional before the test if you have ever had an allergic reaction to iodine or iodine-containing substances.
  • You will be monitored for a period after the injection in case of an allergic reaction.
  • Tell your healthcare professional if you are pregnant, could become pregnant, or are breastfeeding, before undergoing this test.
  • The dye can interfere with certain other laboratory tests, including radioactive iodine studies, for about a week afterward.

References

Source material and product information

  1. Health Canada Product Monograph — Indocyanine Green

For professional reference. Confirm patient-specific decisions against the current approved product monograph and applicable clinical guidance.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.